Study of tradipitant for severe or critical COVID-19
Treatments studied
Part of Infections clinical trials.
This trial tests whether tradipitant can improve outcomes for adults with severe or critical COVID-19, including pneumonia and low oxygen. It may help patients whose lungs are significantly affected and who need careful hospital-level care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 90
- You have a confirmed COVID-19 infection test (RT-PCR)
- Your hospital says your COVID-19 is severe or critical
- You have pneumonia seen on a chest X-ray or CT scan
- You have low oxygen (oxygen saturation under 92%) or fever as defined by the study
- You are not pregnant and can give consent (or a legal representative can)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This trial tests a new drug, ratutrelvir, for people with mild to moderate COVID-19. It aims to find a safe and effective dose to help you feel better faster.
This early-stage study tests COVID-19 treatments in people who have recently developed symptoms and who test positive for the virus. It aims to find safer, more effective options for preventing worsening disease, especially in higher-risk groups.
This trial tests an investigational medicine called Trimodulin (BT588) for people with severe pneumonia who need a breathing machine. The goal is to see if it helps them recover faster.
This trial tests a new approach to treating serious respiratory infections in hospitalized adults. It aims to see if a targeted strategy works better than standard care while avoiding extra risks.
This trial tests if a new medicine called ibuzatrelvir can help people with COVID-19 who have certain health risks avoid severe illness. It is for patients who cannot or choose not to take another COVID-19 pill called Paxlovid.
Hear when a new Coronavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.